12:00 AM
May 13, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Blood-based autism test: Clinical trial started

SynapDx Corp., Southborough, Mass.
Product: Blood-based autism test ( SDX-002)
Business: Diagnostic
Molecular target: NA
Description: Blood-based RNA gene expression profiling test
Indication: Identify autism spectrum disorder (ASD)
Endpoint: RNA gene expression in...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >